• Supplemental experience significantly improves overall survival and progression-free survival in advanced cancer patients.
• Quality of life is enhanced with supplemental experience, with a moderate effect size.
• The safety profile of supplemental experience is comparable to standard care, with no significant increase in severe adverse events.
• These findings suggest that supplemental experience could be integrated into clinical practice as an adjunctive treatment for advanced cancer.
Download Full PDF: Supplemental Experience and Clinical Outcomes in Patients with Advanced Cancer: A Systematic Review and Meta-Analysis | SinoBioData | SinoBioData